SEC Form 4/A · accession 0001209191-15-058357
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 2, 2015 | S | 1,715 | $11.4607 | D | 68,498 | D |
Table II — derivative securities
Explanation of responses
- F172,623 shares of restricted stock (as adjusted from 41,499 shares prior to the 1.75-for-1 stock split effected on March 6, 2014) were awarded on December 23, 2013. Twenty-five percent of the shares vested on December 2, 2014. The remaining shares vest in equal quarterly installments over the following three years until fully vested.
- F2Shares sold by reporting person pursuant to a 10b5-1 plan to pay taxes in connection with the vesting of restricted stock pursuant to the December 23, 2013 award described in footnote 1.
- F3The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.25 to $11.64, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Remarks
This Form 4/A amends the Form 4 filing made on behalf of the Reporting Person on January 5, 2015. The Form 4, as originally filed, incorrectly reported the time-based vesting of 4,539 shares of restricted stock on January 1, 2015, which restricted stock had previously been reported in Table I. The amount of securities beneficially owned in Table I, Column 5 as of January 1, 2015 was incorrectly reported as 74,752. The correct total as of January 1, 2015 was 70,213. The amount of securities beneficially owned in Table I, Column 5 as of January 2, 2015 was incorrectly reported as 73,037. The correct total on January 2, 2015 was 68,498. Footnote 4 in the January 5, 2015 filing incorrectly stated that shares were purchased when they were in fact sold.